An exome array study of the plasma metabolome

Area of Science:

• Genetics
• Metabolomics
• Human Physiology

Background:

• Understanding the genetic underpinnings of the human metabolome is crucial for deciphering complex diseases.
• Rare genetic variants play a significant role in metabolic pathways, yet their contribution is often understudied.
• Previous genome-wide association studies have provided a foundation for exploring genetic determinants of metabolites.

Purpose of the Study:

• To analyze the association between plasma metabolites and exome variants.
• To identify novel coding variants influencing metabolite levels and heritability.
• To integrate findings from rare and common variants for a comprehensive view of metabolic genetic architecture.

Main Methods:

• Analysis of 217 plasma metabolites and exome variants in 2,076 Framingham Heart Study participants.
• Replication analysis in 1,528 participants from the Atherosclerosis Risk in Communities Study.
• Utilized single variant and gene-based tests, including meta-analysis for robust association detection.

Main Results:

• Identified significant associations between specific genes (GMPS, HAL, PAH, UPB1) and metabolites (xanthosine, histidine, phenylalanine, ureidopropionate).
• Highlighted novel coding variants potentially responsible for inborn errors of metabolism.
• Demonstrated that examining variants across the allele frequency spectrum reveals independent signals and enhances metabolite heritability insights.

Conclusions:

• Rare variants are important contributors to the genetic architecture of the plasma metabolome.
• The identified gene-metabolite associations provide new targets for understanding metabolic disorders.
• Integrating rare and common variant data offers a more complete picture of metabolite heritability.